Shots: The P-III TOURMALINE-AL1 (NCT01659658) study involves assessing of Ninlaro + dexamethasone vs dexamethasone + (melphalan/ cyclophosphamide/ thalidomide/ lenalidomide)/ monothx in patients with relapsed or refractory systemic light chain (AL) […]readmore
